Medicinova Stock Technical Analysis
| MNOV Stock | USD 1.32 0.03 2.33% |
As of the 2nd of May, MediciNova secures the Risk Adjusted Performance of (0.03), mean deviation of 2.06, and Standard Deviation of 2.62. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MediciNova, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to break down and interpolate data for thirteen technical drivers for MediciNova, which can be compared to its peers in the industry. Please verify MediciNova mean deviation and maximum drawdown to decide if MediciNova is priced some-what accurately, providing market reflects its recent price of 1.32 per share. Given that MediciNova is a hitting penny stock territory we strongly suggest to closely look at its jensen alpha.
MediciNova Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as MediciNova, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MediciNovaMediciNova |
MediciNova Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 16.5 | Strong Buy | 1 | Odds |
Most MediciNova analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand MediciNova stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of MediciNova, talking to its executives and customers, or listening to MediciNova conference calls.
MediciNova technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
MediciNova Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of MediciNova volatility. High ATR values indicate high volatility, and low values indicate low volatility.
MediciNova Trend Analysis
Use this graph to draw trend lines for MediciNova. You can use it to identify possible trend reversals for MediciNova as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual MediciNova price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.MediciNova Best Fit Change Line
The following chart estimates an ordinary least squares regression model for MediciNova applied against its price change over selected period. The best fit line has a slop of 0.0008 , which means MediciNova will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.02, which is the sum of squared deviations for the predicted MediciNova price change compared to its average price change.About MediciNova Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of MediciNova on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of MediciNova based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on MediciNova price pattern first instead of the macroeconomic environment surrounding MediciNova. By analyzing MediciNova's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of MediciNova's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to MediciNova specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Days Sales Outstanding | 328.79 | 292.26 | PTB Ratio | 1.18 | 1.63 |
MediciNova May 2, 2024 Technical Indicators
Most technical analysis of MediciNova help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for MediciNova from various momentum indicators to cycle indicators. When you analyze MediciNova charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.87) | |||
| Mean Deviation | 2.06 | |||
| Coefficient Of Variation | (1,594) | |||
| Standard Deviation | 2.62 | |||
| Variance | 6.85 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.88) | |||
| Maximum Drawdown | 14.01 | |||
| Value At Risk | (3.95) | |||
| Potential Upside | 4.55 | |||
| Skewness | 0.5159 | |||
| Kurtosis | 0.6287 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for MediciNova Stock analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is MediciNova's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MediciNova. If investors know MediciNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MediciNova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.17) | Revenue Per Share 0.02 | Return On Assets (0.09) | Return On Equity (0.13) |
The market value of MediciNova is measured differently than its book value, which is the value of MediciNova that is recorded on the company's balance sheet. Investors also form their own opinion of MediciNova's value that differs from its market value or its book value, called intrinsic value, which is MediciNova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MediciNova's market value can be influenced by many factors that don't directly affect MediciNova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MediciNova's value and its price as these two are different measures arrived at by different means. Investors typically determine if MediciNova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MediciNova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.